ELECTROMED INC (ELMD) — insider trading
Health Care · Nyse Mkt Llc
ELECTROMED INC (ELMD) has 30 reported SEC Form 4 insider transactions in our data, including 14 open-market sales among the most recent 30 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Nagel Bradley M. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 674 | $42.30 | $28.5K | Form 4 |
| 2026-06-08 | Cunniff James L. | Director, Officer (CEO and President) | Option exercise / conversion (derivative) | 9,700 | $0.00 | $0 | Form 4 |
| 2026-06-08 | Cunniff James L. | Director, Officer (CEO and President) | Open-market sale | 1,026 | $37.77 | $38.8K | Form 4 |
| 2026-06-08 | Cunniff James L. | Director, Officer (CEO and President) | Open-market sale | 1,671 | $36.80 | $61.5K | Form 4 |
| 2026-06-08 | Cunniff James L. | Director, Officer (CEO and President) | Open-market sale | 7,003 | $36.25 | $253.9K | Form 4 |
| 2026-06-08 | Cunniff James L. | Director, Officer (CEO and President) | Option exercise / conversion | 9,700 | $17.25 | $167.3K | Form 4 |
| 2026-06-04 | Nagel Bradley M. | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 5,267 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Nagel Bradley M. | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 4,334 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Nagel Bradley M. | Officer (Chief Financial Officer) | Open-market sale | 181 | $37.11 | $6.7K | Form 4 |
| 2026-06-04 | Nagel Bradley M. | Officer (Chief Financial Officer) | Open-market sale | 11,620 | $36.34 | $422.2K | Form 4 |
| 2026-06-04 | Nagel Bradley M. | Officer (Chief Financial Officer) | Option exercise / conversion | 5,267 | $10.71 | $56.4K | Form 4 |
| 2026-06-04 | Nagel Bradley M. | Officer (Chief Financial Officer) | Option exercise / conversion | 4,334 | $10.25 | $44.4K | Form 4 |
| 2026-05-15 | SKARVAN KATHLEEN | Director | Option exercise / conversion (derivative) | 40,000 | $0.00 | $0 | Form 4 |
| 2026-05-15 | SKARVAN KATHLEEN | Director | Open-market sale | 3,562 | $37.33 | $133.0K | Form 4 |
| 2026-05-15 | SKARVAN KATHLEEN | Director | Open-market sale | 9,256 | $36.26 | $335.6K | Form 4 |
| 2026-05-15 | SKARVAN KATHLEEN | Director | Open-market sale | 19,032 | $35.24 | $670.7K | Form 4 |
| 2026-05-15 | SKARVAN KATHLEEN | Director | Open-market sale | 8,150 | $34.36 | $280.1K | Form 4 |
| 2026-05-15 | SKARVAN KATHLEEN | Director | Option exercise / conversion | 40,000 | $3.82 | $152.8K | Form 4 |
| 2025-12-01 | Summers Andrew | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-12-01 | Walsh Andrea M. | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-12-01 | SKARVAN KATHLEEN | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-12-01 | Galatowitsch Joseph L. | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-12-01 | Fluet Gregory | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-12-01 | Erickson Stan K. | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-12-01 | Tune Kathleen A | Director | Grant / award / vesting | 3,000 | $0.00 | $0 | Form 4 |
| 2025-09-11 | Summers Andrew | Director | Open-market sale | 3,153 | $24.42 | $77.0K | Form 4 |
| 2025-09-10 | Summers Andrew | Director | Open-market sale | 404 | $26.62 | $10.8K | Form 4 |
| 2025-09-10 | Summers Andrew | Director | Open-market sale | 6,576 | $25.94 | $170.6K | Form 4 |
| 2025-09-10 | Summers Andrew | Director | Open-market sale | 16,203 | $25.16 | $407.7K | Form 4 |
| 2025-09-10 | Summers Andrew | Director | Open-market sale | 39,378 | $23.68 | $932.4K | Form 4 |
Ask the chat about ELMD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ELECTROMED INC (ELMD).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.